Salus at Drexel University to host continuing education event titled ‘Medical Marijuana
#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians increasingly encounter patients using or asking about cannabis for symptom management, making foundational knowledge of endocannabinoid physiology essential for informed clinical conversations and risk-benefit assessments. Understanding how cannabinoids interact with the body’s endogenous systems enables providers to give evidence-based guidance on potential therapeutic applications and drug interactions rather than defaulting to outdated prohibitionist stances. As cannabis legalization expands across states, clinicians who lack this basic pharmacologic knowledge risk being unable to counsel patients effectively or recognize cannabis-related harms and benefits in their populations.
Drexel University’s Salus Institute is hosting a continuing education event designed to enhance physician understanding of cannabis pharmacology and clinical application through structured discussion of endocannabinoid system physiology. The program will feature experienced practitioners sharing practical insights into how the endogenous endocannabinoid system functions and its relevance to therapeutic cannabis use. This educational initiative addresses a significant knowledge gap in medical training, as most physicians receive minimal formal instruction on cannabinoid pharmacology despite increasing legalization and patient interest in cannabis-based treatment. By providing evidence-based education on the biological mechanisms underlying cannabinoid effects, the event aims to improve clinician competence in patient counseling, risk assessment, and appropriate therapeutic consideration of cannabis across various conditions. Participation in such continuing education can help clinicians make more informed decisions when discussing cannabis use with patients and better understand potential drug interactions and contraindications. Clinicians should consider attending such programs to build foundational knowledge of endocannabinoid biology, which is increasingly important for having evidence-based conversations with patients about cannabis as a potential therapeutic option.
“The endocannabinoid system is as fundamental to human physiology as the nervous or immune system, yet most physicians graduate without understanding it, which means we’re making treatment decisions in the dark. Until we integrate endocannabinoid science into standard medical education, we’ll continue to see patients self-treating conditions that we could address more effectively with proper clinical knowledge.”
? As cannabis legalization expands across jurisdictions, healthcare providers increasingly encounter patients seeking medical cannabis for various conditions, yet many clinicians lack foundational knowledge about endocannabinoid physiology or evidence-based prescribing frameworks. Educational initiatives like continuing education events on medical cannabis can help bridge this knowledge gap by reviewing the endogenous cannabinoid system’s role in pain, inflammation, seizure control, and other physiological processes, though clinicians should recognize that mechanistic plausibility does not always translate to clinical efficacy and that robust, high-quality trials remain limited for many proposed indications. Participation in such programs also provides opportunities to learn from practitioners with clinical experience in cannabis medicine, which can contextualize the gaps between preclinical science, available evidence, and real-world practice patterns. However, providers should approach cannabis recommendations with the same rigor applied to other therapeutics, considering product standardization challenges, drug interaction potential,
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it:
